The FDA approved a once-daily oral GLP-1 receptor agonist for adults with obesity or overweight with weight-related comorbidities, Eli Lilly announced.

Dyslipidemia is highly prevalent and the primary direct driver of atherosclerotic CVD. In the more than 7 years since the last American Heart Association/American College of Cardiology/Multisociety Ch...

Women with hypothyroidism receiving levothyroxine treatment have similar cardiovascular disease risk as those without thyroid disease, according to data published in Thyroid. In an analysis of 2,647 w...

The rate of out-of-hospital cardiac arrest the first day back to work after multiday holidays was significantly higher compared with other workdays, according to data published in JAMA Network Open.Th...

In-hospital mortality was significantly higher for younger women vs. younger men after a first heart attack, with women receiving fewer cardiac procedures and having more nontraditional cardiovascular...

A prior history of ischemic stroke may signal higher risk for another stroke during pregnancy and in the early postpartum period, researchers reported at the International Stroke Conference.

Heart disease remains the leading cause of death for women. Despite advancements in awareness and research, gaps remain in the diagnosis and treatment of cardiovascular disease in women.February is Am...

President Donald J. Trump signed a new memorandum that aims to crack down on “misleading” direct-to-consumer pharmaceutical advertisements. On Sept. 9, Trump issued a memorandum to HHS Sec...

Presence of CV risk factors may cause the heart to “age” faster than a person’s chronological age, and social determinants of health may exacerbate this heart age discordance, resear...

The latest news from the ESC Congress, with physician perspective, researcher interviews and clinician insight.

A scientific statement on prevention of heart failure, a relatively new concept, has been released.The statement from the Heart Failure Society of America and the American Society for Preventive Cardi...

BOSTON — Much of the health-related content about cholesterol on social media, in particular TikTok, is inaccurate, according to research presented at the American Society for Preventive Cardiol...

Members of an FDA expert panel discussed reassessing boxed warnings for menopausal HT and how to better educate patients and health care professionals.

Drinking coffee may provide anti-inflammatory benefits leading to potential reductions in future risk for heart disease, according to a state-of-the-art review published in the European Heart Journal....

Fewer patients with autoimmune disease are dying due to cardiovascular disease, but women remain at higher risk vs. men, according to data published in Circulation: Cardiovascular Quality and Outcomes...

The latest news from the ACC Annual Scientific Session, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention, heart failure and more.

CHICAGO — Lepodisiran, a small interfering RNA agent, lowered lipoprotein(a) levels at 180 days, with a reduction of more than 90 percentage points with a single 400-mg dose compared with placeb...

CHICAGO — The first trial to evaluate use of an SGLT2 inhibitor in people undergoing transcatheter aortic valve replacement showed benefit with dapagliflozin compared with standard care alone, i...

CHICAGO — A new study that looked at how liberal vs. restrictive fluid restriction impacts health status for patients with chronic heart failure found no added risks or benefits with either stra...

CHICAGO — Among women with suspected ischemia with nonobstructive coronary disease, an intensive medical therapy strategy did not reduce risk for major adverse CV events at 5 years compared with...

The latest news from the AHA Scientific Sessions, with physician perspective, researcher interviews and clinician insight on cardiovascular prevention and more.